Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
ADIL | US
0.06
5.94%
Healthcare
Biotechnology
30/06/2024
21/10/2024
1.07
1.04
1.10
1.03
Adial Pharmaceuticals Inc. a clinical-stage biopharmaceutical company focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its lead product is AD04 a serotonin-3 antagonist which is in Phase III clinical trial for the treatment of alcohol use disorder. The company also focuses on developing drug candidates for non-opioid pain reduction and other diseases and disorders. Adial Pharmaceuticals Inc. was founded in 2010 and is based in Charlottesville Virginia.
View LessStrength based on increasing price with high volume
High Current Volume and Positive 1-Day Return
Value Stock (Price to Book < 3)
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
63.7%1 month
52.4%3 months
74.5%6 months
78.5%-
-
1.45
-
-
-0.49
-
-
-7.27M
6.85M
6.85M
-
-
-
-
-320.96
0.72
1.24
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
0.16
Range1M
0.16
Range3M
2.10
Rel. volume
2.99
Price X volume
318.03K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Pulmatrix Inc | PULM | Biotechnology | 2.04 | 7.45M | 0.97% | n/a | 0.18% |
Cyclerion Therapeutics Inc | CYCN | Biotechnology | 2.9099 | 7.32M | 16.40% | n/a | 0.00% |
Orgenesis Inc | ORGS | Biotechnology | 1.53 | 7.30M | -27.49% | n/a | -84.02% |
Virax Biolabs Group Limited Ordinary Shares | VRAX | Biotechnology | 1.63 | 7.08M | 6.54% | n/a | 4.18% |
Purple Biotech Ltd | PPBT | Biotechnology | 4.49 | 7.07M | 2.75% | n/a | 0.89% |
CDIO | CDIO | Biotechnology | 0.231 | 7.07M | 9.53% | n/a | 28.31% |
Galmed Pharmaceuticals Ltd | GLMD | Biotechnology | 4.68 | 7.05M | 23.16% | n/a | 0.00% |
Vaccinex Inc - Ordinary Shares | VCNX | Biotechnology | 2.69 | 6.99M | 6.32% | n/a | -4.26% |
Aptose Biosciences Inc | APTO | Biotechnology | 0.3889 | 6.96M | 6.75% | n/a | -37.59% |
Oncternal Therapeutics Inc | ONCT | Biotechnology | 2.09 | 6.19M | 45.64% | n/a | 1.49% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Twin Vee PowerCats Co. Common Stock | VEEE | Recreational Vehicles | 0.4659 | 4.44M | -2.96% | n/a | 19.98% |
Forza X1 Inc | FRZA | Recreational Vehicles | 0.19 | 2.99M | -13.68% | n/a | 0.97% |
EZGO Technologies Ltd. Ordinary Shares | EZGO | Recreational Vehicles | 1.06 | 2.71M | 0.00% | n/a | 17.32% |
Vision Marine Technologies Inc | VMAR | Recreational Vehicles | 3.65 | 2.01M | -6.89% | n/a | 0.00% |
Micromobility.com Inc. | MCOM | Recreational Vehicles | 0.011 | 1.01M | 10.00% | n/a | -37.05% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | -0.49 | 0.53 | Cheaper |
Ent. to Revenue | - | 3,967.00 | - |
PE Ratio | - | 41.03 | - |
Price to Book | 1.45 | 15.55 | Cheaper |
Dividend Yield | - | 2.20 | - |
Std. Deviation (3M) | 74.49 | 72.80 | Par |
Debt to Equity | - | -1.23 | - |
Debt to Assets | - | 0.25 | - |
Market Cap | 6.85M | 3.66B | Emerging |